Great news for pain and CNS management in RSA
Acino has collaborated with Janssen, the Pharmaceutical Company of Johnson & Johnson in South Africa, to enhance patient access to several medicines. Acino will now market and sell several of their products, focusing on pain, CNS (Central Nervous System) and Infectiology therapeutic areas in South Africa.
Recent Posts
Dutch Elderly Care Challenges: Navigating Fragmentation in Support Systems
A recently published visualization from Zorginstituut Nederland illustrates the intricate pathways through which an elderly individual with progressive dementia, such as Mrs. Mahabier, encounters multiple statutory frameworks, care providers, and administrative entities as her needs evolve. It de...
FDA Endorses Truqap Prostate Cancer Therapy for PTEN-Deficient Cases
Truqap Prostate Cancer Therapy gains key backing from FDA advisors for PTEN-deficient metastatic hormone-sensitive prostate cancer, following strong data from the pivotal trial that demonstrated meaningful delays in disease progression.
ODAC Backs Targeted Therapy
The ...
Unlocking the Benefits of Cardiovascular Health Checks in EU Prevention Strategies
Cardiovascular health checks deliver strong clinical, economic and societal value when delivered as structured, risk-based programmes connected to ongoing care. This approach supports EU cardiovascular prevention strategies by catching cardiometabolic risks early and reducing long-term events. Th...